出版社 | MarketsandMarkets |
出版年月 | 2025年1月 |
Cardiovascular Devices Market – Global Forecast To 2029
The growth of the cardiovascular devices market is driven by several key factors, most notably the increasing prevalence of cardiovascular diseases (CVD) worldwide, advancements in minimally invasive procedures, and growing demand for improved patient outcomes and lastly shifting preference to remote monitoring. As rates of heart disease rise, the need for effective monitoring and treatments such as angioplasty, stenting, and valve replacements also increases where these devices are implemented. Technological innovations, including the development of drug-eluting stents, bioresorbable scaffolds and occluders, and advanced imaging technologies, have enabled safer and more precise procedures, which contribute to the market’s growth.
心臓血管用デバイス市場の成長は、いくつかの重要な要因によって推進されており、最も顕著なのは、世界的な心血管疾患(CVD)の有病率の増加、低侵襲処置の進歩、患者転帰の改善に対する需要の高まり、そして最後に遠隔モニタリングへの優先の移行です。心臓病の発生率が上昇するにつれて、血管形成術、ステント留置術、弁置換術などの効果的なモニタリングと治療の必要性も、これらの装置が導入されている地域では増加しています。薬剤溶出性ステント、生体吸収性足場と閉塞材、高度な画像技術の開発などの技術革新により、より安全で正確な処置が可能になり、市場の成長に貢献しています。

Key players in the cardiovascular devices market
Some of the prominent players operating in the cardiovascular devices market include Medtronic Plc (Ireland), Abbott Laboratories (US), Boston Scientific Corporation (US), Terumo Corporation (Japan), GE Healthcare Technologies, Inc. (US), Edward Lifesciences Corporation (US), Siemens Healthineers AG (Germany), Johnson & Johnson (US), Baxter International Inc (US), B. Braun SE (Germany), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Lepu Medical Technology (Beijing) Co., Ltd (China), Nihon Kohden Corporation (Japan), MicroPort Scientific Corporation (China), Japan Lifeline Co., Ltd. (Japan), AngioDynamics, Inc.(US), LifeTech Scientific Corporation (China), Artivion Inc (US), Sahajanand Medical Technologies Limited (India), OrbusNeich Medical Group Holdings Limited (China), BPL Medical Technologies (India), BiotroniK. (Germany),), W.L. Gore & Associates, Inc (US), Canon medical systems corporation (Japan), Picard Medical Company (US).
This report provides insights into the following pointers:
- Of Analysis of key drivers (The increase in prevalence of cardiovascular diseases, The increasing preference for minimally invasive techniques, Technological Advancements Fueling Innovation in Cardiovascular Devices, Rise in Remote Patient Monitoring), restraints (Stringent regulatory guidelines for product approval, Lack of skilled Cardiovascular Healthcare professionals), opportunities (Projected Growth in the Elderly Population, Emerging Opportunities in Biodegradable Cardiovascular Devices) and challenges (Product failures and recalls, Adverse Effects and Complications with usage of implantable cardiovascular devices).
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global cardiovascular devicesmarket.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global cardiovascular devices market
- Market Development: Comprehensive information on the lucrative emerging markets by product, indication and enduser.
- Market Diversification: Exhaustive information about new product or product enhancements, growing geographies, recent developments, and investments in the global cardiovascular devices market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global cardiovascular devices market.